Dynamics of humoral immune response in SARS-CoV-2 infected individuals with different clinical stages

por Mendez-Cortina, Yorjagis, Rodriguez-Perea, Ana Lucía, Chvatal-Medina, Mateo, Lopera, Tulio Jose, Alvarez-Mesa, Natalia, Rodas-Marín, Jan Karlo, Moncada, Diana Carolina, Rugeles, Maria Teresa, Velilla, Paula Andrea
Publicado 2022

Correction to: LHRH sparing therapy in patients with chemotherapy-naïve, mCRPC treated with abiraterone acetate plus prednisone: results of the randomized phase II SPARE trial

por Ohlmann, Carsten-Henning, Jäschke, Michelle, Jaehnig, Peter, Krege, Susanne, Gschwend, Jürgen, Rexer, Heidrun, Junker, Kerstin, Zillmann, Roger, Rüssel, Christoph, Hellmis, Eva, Suttmann, Henrik, Janssen, Martin, Marin, Jan, Hübner, Andreas, Mathers, Michael, Gleißner, Jochen, Scheffler, Michael, Feyerabend, Susan, Telle, Jens, Klier, Jörg, Stöckle, Michael
Publicado 2023

LHRH sparing therapy in patients with chemotherapy-naïve, mCRPC treated with abiraterone acetate plus prednisone: results of the randomized phase II SPARE trial

por Ohlmann, Carsten-Henning, Jäschke, Michelle, Jaehnig, Peter, Krege, Susanne, Gschwend, Jürgen, Rexer, Heidrun, Junker, Kerstin, Zillmann, Roger, Rüssel, Christoph, Hellmis, Eva, Suttmann, Henrik, Janssen, Martin, Marin, Jan, Hübner, Andreas, Mathers, Michael, Gleißner, Jochen, Scheffler, Michael, Feyerabend, Susan, Telle, Jens, Klier, Jörg, Stöckle, Michael
Publicado 2022